Elevated SHBG reduced the pool of bioavailable androgens, thereby mitigating the hyperandrogenic drive, while reductions in circulating testosterone directly alleviated clinical manifestations such as hirsutism and acne in the CL22209-supplemented subjects. The gene discussed is SHBG; the disease is acne.